Granted Patent
B2
US 8,119,661 · App. 12/205,968 · Granted Feb 21, 2012
Piperidine derivatives and their use as muscarinic receptor modulators
Assignee:
AstraZeneca AB
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Compounds of Formula I, or pharmaceutically acceptable salts thereof: wherein R 2 , R 3 , X, m and n are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
Claims (1)
1. Propan-2-yl 4-[4-[(3aS,7aS)-2-oxo-3a,4,5,6,7,7a-hexahydro-3H-benzoimidazol-1-yl]-1-piperidyl]-4-methyl-piperidine-1-carboxylate or a pharmaceutically acceptable salt thereof.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Oct 31, 2008
From: CHENG, YUN-XING; LUO, XUEHONG; SANTHAKUMAR, VIJAYARATNAM; TOMASZEWSKI, MIROSLAW JERZY
To: ASTRAZENECA AB
Reel/Frame 021767/0523 →
Continuity (2)
Provisional Application
60971288
· Sep 11, 2007